GDF15 and myalgic encephalomeyelitis/chronic fatigue syndrome: We found statistically significant differencesbetween mean GDF-15 levels in patients with PMM and those inpatients with CFS, and also between patients with PMM and in patients with non-mitochondrial disease (p = 0.0001 and p = 0.0101, respectively).